Literature DB >> 31163450

Functional brain networks in never-treated and treated long-term Ill schizophrenia patients.

Li Yao1,2, Fei Li1,2, Jieke Liu3, Wei Liao4, Xiaojing Li5,6, Mingli Li5,6, Yajing Meng5,6, Sugai Liang5,6, Chengcheng Zhang5,6, Xiao Yang5,6, Qiang Wang5,6, Xiaohong Ma5,6, Wanjun Guo5,6, John A Sweeney1,2,7, Qiyong Gong1,2, Su Lui1,2, Wei Deng8,9, Tao Li5,6.   

Abstract

This study compared the topological organization of brain function in never-treated and treated long-term schizophrenia patients. In a cross-sectional study, 21 never-treated schizophrenia patients with illness duration over 5 years, 26 illness duration-matched antipsychotic-treated patients and 24 demographically-matched healthy controls underwent a resting-state functional magnetic resonance imaging (MRI) scan. The topological properties of brain functional networks were compared across groups, and then we tested for differential age-related effects in regions with significant group differences. Both never-treated and antipsychotic-treated schizophrenia patient groups showed altered nodal centralities in left pre-/postcentral gyri relative to controls. Never-treated patients demonstrated reduced global efficacy, decreased nodal centralities in right amygdala/hippocampus and bilateral putamen/caudate relative to antipsychotic-treated patients and controls. No significant relationships of age and altered functional metrics were seen in either patient group, and no alterations were greater in the treated group. These findings provide insight into brain function deficits over the longer-term course of schizophrenia independent from potential effects of antipsychotic medication. The presence of greater alterations in never-treated than treated patients suggests that long-term antipsychotic treatment may partially protect or enhance brain global and nodal topological function over the course of schizophrenia, notably involving the amygdala, hippocampus, and striatum that have long been associated with the disorder.

Entities:  

Mesh:

Year:  2019        PMID: 31163450      PMCID: PMC6784906          DOI: 10.1038/s41386-019-0428-2

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  67 in total

Review 1.  Effects of medication on neuroimaging findings in bipolar disorder: an updated review.

Authors:  Danella M Hafeman; Kiki D Chang; Amy S Garrett; Erica M Sanders; Mary L Phillips
Journal:  Bipolar Disord       Date:  2012-06       Impact factor: 6.744

2.  Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.

Authors:  Robert M Kessler; Mohammad Sib Ansari; Patrizia Riccardi; Rui Li; Karuna Jayathilake; Benoit Dawant; Herbert Y Meltzer
Journal:  Neuropsychopharmacology       Date:  2005-12       Impact factor: 7.853

3.  Collective dynamics of 'small-world' networks.

Authors:  D J Watts; S H Strogatz
Journal:  Nature       Date:  1998-06-04       Impact factor: 49.962

4.  Psychoradiologic Utility of MR Imaging for Diagnosis of Attention Deficit Hyperactivity Disorder: A Radiomics Analysis.

Authors:  Huaiqiang Sun; Ying Chen; Qiang Huang; Su Lui; Xiaoqi Huang; Yan Shi; Xin Xu; John A Sweeney; Qiyong Gong
Journal:  Radiology       Date:  2017-11-22       Impact factor: 11.105

5.  Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.

Authors:  G D Honey; E T Bullmore; W Soni; M Varatheesan; S C Williams; T Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

6.  Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia.

Authors:  Wenjing Zhang; Wei Deng; Li Yao; Yuan Xiao; Fei Li; Jieke Liu; John A Sweeney; Su Lui; Qiyong Gong
Journal:  Am J Psychiatry       Date:  2015-06-18       Impact factor: 18.112

7.  Accelerated Gray and White Matter Deterioration With Age in Schizophrenia.

Authors:  Vanessa L Cropley; Paul Klauser; Rhoshel K Lenroot; Jason Bruggemann; Suresh Sundram; Chad Bousman; Avril Pereira; Maria A Di Biase; Thomas W Weickert; Cynthia Shannon Weickert; Christos Pantelis; Andrew Zalesky
Journal:  Am J Psychiatry       Date:  2016-12-06       Impact factor: 18.112

Review 8.  Connectome and schizophrenia.

Authors:  Katherine L Narr; Amber M Leaver
Journal:  Curr Opin Psychiatry       Date:  2015-05       Impact factor: 4.741

9.  Eye tracking abnormalities in schizophrenia: evidence for dysfunction in the frontal eye fields.

Authors:  J A Sweeney; B Luna; N M Srinivasagam; M S Keshavan; N R Schooler; G L Haas; J R Carl
Journal:  Biol Psychiatry       Date:  1998-10-15       Impact factor: 13.382

10.  Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.

Authors:  Jennifer A Hadley; Rodolphe Nenert; Nina V Kraguljac; Mark S Bolding; David M White; Frank M Skidmore; Kristina M Visscher; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2013-10-29       Impact factor: 7.853

View more
  6 in total

1.  Disrupted Intersubject Variability Architecture in Functional Connectomes in Schizophrenia.

Authors:  Xiaoyi Sun; Jin Liu; Qing Ma; Jia Duan; Xindi Wang; Yuehua Xu; Zhilei Xu; Ke Xu; Fei Wang; Yanqing Tang; Yong He; Mingrui Xia
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

2.  Conceptual disorganization and redistribution of resting-state cortical hubs in untreated first-episode psychosis: A 7T study.

Authors:  Avyarthana Dey; Kara Dempster; Michael MacKinley; Peter Jeon; Tushar Das; Ali Khan; Joe Gati; Lena Palaniyappan
Journal:  NPJ Schizophr       Date:  2021-01-26

3.  Abnormal nodal and global network organization in resting state functional MRI from subjects with the 22q11 deletion syndrome.

Authors:  Teuntje A D Pelgrim; Matthijs G Bossong; Analía Cuiza; Luz María Alliende; Carlos Mena; Angeles Tepper; Juan Pablo Ramirez-Mahaluf; Barbara Iruretagoyena; Claudia Ornstein; Rosemarie Fritsch; Juan Pablo Cruz; Cristian Tejos; Gabriela Repetto; Nicolas Crossley
Journal:  Sci Rep       Date:  2021-11-03       Impact factor: 4.379

Review 4.  The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies.

Authors:  Chengmin Yang; Jing Tang; Naici Liu; Li Yao; Mengyuan Xu; Hui Sun; Bo Tao; Qiyong Gong; Hengyi Cao; Wenjing Zhang; Su Lui
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

5.  Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients.

Authors:  Nian Liu; Yuan Xiao; Wenjing Zhang; Biqiu Tang; Jiaxin Zeng; Na Hu; Shah Chandan; Qiyong Gong; Su Lui
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

6.  Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated.

Authors:  Chunyan Luo; Rebekka Lencer; Na Hu; Yuan Xiao; Wenjing Zhang; Siyi Li; Su Lui; Qiyong Gong
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-29       Impact factor: 5.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.